News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
372 Results
Type
Article (24)
Press Release (348)
Section
Business (143)
Deals (15)
Drug Development (57)
FDA (5)
Job Trends (6)
News (197)
Policy (17)
Tag
Academia (2)
Alliances (13)
Alzheimer's disease (1)
Approvals (7)
Best Places to Work (6)
Clinical research (54)
COVID-19 (9)
Data (2)
Diagnostics (1)
Earnings (122)
Events (101)
FDA (9)
GLP-1 (1)
Government (3)
Guidances (1)
Healthcare (3)
Infectious disease (9)
IPO (13)
Legal (1)
Medical device (2)
Medtech (2)
Mergers & acquisitions (2)
Neuroscience (1)
NextGen: Class of 2026 (4)
People (27)
Phase 1 (16)
Phase 2 (39)
Phase 3 (28)
Pipeline (4)
Postmarket research (2)
Preclinical (1)
Real estate (1)
Regulatory (17)
Startups (1)
Date
Last 30 days (1)
Last 365 days (23)
2026 (2)
2025 (26)
2024 (39)
2023 (43)
2022 (61)
2021 (61)
2020 (55)
2019 (11)
2017 (16)
2016 (2)
2015 (31)
2014 (20)
2011 (1)
2010 (1)
Location
Asia (220)
Australia (2)
Europe (30)
Massachusetts (27)
Missouri (1)
United States (28)
372 Results for "mediwound".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 21, 2025
·
15 min read
Press Releases
MediWound’s NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress
September 3, 2025
·
3 min read
Press Releases
MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia
September 26, 2025
·
5 min read
Press Releases
MediWound to Present at the H.C. Wainwright 27th Annual Global Investment Conference
August 20, 2025
·
1 min read
Press Releases
MediWound Reports Second Quarter 2025 Financial Results and Provides Corporate Update
August 15, 2025
·
15 min read
Press Releases
MediWound Announces New EscharEx® Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers
August 14, 2025
·
6 min read
Press Releases
MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 21, 2025
·
15 min read
Press Releases
MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers
May 14, 2025
·
6 min read
Business
MediWound Reports First Quarter 2024 Financial Results and Provides Company Update
MediWound Ltd., the global leader in next-generation enzymatic therapeutics for tissue repair, announced financial results for the first quarter ended March 31, 2024, and provided a corporate update.
May 29, 2024
·
14 min read
Press Releases
MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
March 20, 2025
·
16 min read
1 of 38
Next
